European Medicines Agency (EMA)/Heads of Medicines Agencies (HMA)
Climate Impact & Sustainability Data (2020-2025)
Reporting Period: 2020-2025
Environmental Metrics
ESG Focus Areas
- Sustainability of the Network and operational excellence
Climate Goals & Targets
Long-term Goals:
- Ensure a sustainable financial and governance model for the Network.
- Drive digital business transformation.
- Enable quick, consistent, and adequate responses to public health challenges.
Medium-term Goals:
- Build sustainable capability and capacity in data analytics.
- Foster responsible use of antimicrobials.
- Achieve operational excellence within the Network.
Short-term Goals:
- Improve prevention and management of medicine shortages.
- Develop better scientific evidence for decision-making.
- Enhance traceability and oversight in the supply chain.
Environmental Challenges
- Lack of availability of medicines due to supply disruptions or commercial reasons.
- Complexity of data from new treatments and technologies.
- Antimicrobial resistance.
- Supply chain vulnerabilities due to globalization and dependence on third-country manufacturers.
- Need for increased digital transformation and capacity building within the Network.
- Maintaining public trust and stakeholder engagement.
Mitigation Strategies
- Increased collaboration within the EU to address shortages.
- Improved data analytics and digital tools to support regulatory decision-making.
- Responsible use of antimicrobials and development of new alternatives.
- Enhanced traceability and oversight in the medicine supply chain.
- Development of a digital strategy and capacity building initiatives.
- Improved communication and stakeholder engagement.
Supply Chain Management
Responsible Procurement
- International cooperation and collaboration